IRCT20120718010324N81 IRCT 2024-01-04 Tabriz University of Medical Sciences Effect of Probiotic Supplementation on the Incidence of Urinary Tract Infection in the Postpartum Period The Effect of Lactobacillus Acidophilus Probiotic Supplementation on the Incidence of Urinary Tract Infection in the Postpartum Period: A Randomized Controlled Clinical Trial 2023-12-31 anticipated 234 Complete https://irct.ir/trial/73821 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: Allocation sequence will be determined using Randomizer computer software and random block method with block sizes of 4 and 6 and with allocation ratio of 1:1 and stratification based on the type of delivery (vaginal or caesarean section) and sampling setting (hospitals of Al-Zahra, Taleghani or 29 Bahman). Probiotic supplements or placebos will be prepared in sequentially numbered packages based on the allocation sequence. Eligible people will enter the random chain in the order of entering the study and will receive the specified intervention, Blinding description: This research is a triple-blind randomized trial (participant, intervention implementer, data collector and analyst will be unaware of the type of intervention received by groups). Blinding will be performed by a pharmacist colleague at Faculty of Pharmacy of Tabriz University of Medical Sciences through probiotic and placebo capsules in terms of color, appearance, smell, and taste. N/A Urinary tract infection. Intervention 1: Intervention group: The intervention group will take a 500 mg probiotic capsule of Lactobacillus acidophilus strain daily with a glass of water at lunch for 8 weeks. Lactobacillus acidophilus sachet will be prepared from Pishgaman Pakhsh Sadigh Pharmaceutical Company, which is the representative of Christian Hansen Company in Iran. Intervention 2: Control group: The control group will take a 500 mg placebo capsule (containing corn starch) daily with a glass of water at lunch for 8 weeks. Placebo will be prepared by Faculty of Pharmacy of Tabriz University of Medical Sciences. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Participant data is confidential.